Pfizer’s Arthritis Pill Backed by U.S. FDA Advisory Panel

Pfizer’s Arthritis Pill Backed by U.S. FDA Advisory Panel

Michele Tantussi/Bloomberg

Questions will now turn to how broad of an indication Pfizer can get from the FDA, and whether the agency will approve the proposed 5-milligram and 10-milligram doses of tofacitinib.